These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33531929)

  • 1. Medulloblastoma under Siege: Genetic and Molecular Dissection Concerning Recent Advances in Therapeutic Strategies.
    Rawal ZD; Upadhyay VA; Patel DD; Trivedi TI
    J Pediatr Neurosci; 2020; 15(3):175-182. PubMed ID: 33531929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medulloblastoma molecular dissection: the way toward targeted therapy.
    Remke M; Ramaswamy V; Taylor MD
    Curr Opin Oncol; 2013 Nov; 25(6):674-81. PubMed ID: 24076581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Stratification of Medulloblastoma: Clinical Outcomes and Therapeutic Interventions.
    Sursal T; Ronecker JS; Dicpinigaitis AJ; Mohan AL; Tobias ME; Gandhi CD; Jhanwar-Uniyal M
    Anticancer Res; 2022 May; 42(5):2225-2239. PubMed ID: 35489737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medulloblastoma: From Molecular Subgroups to Molecular Targeted Therapies.
    Wang J; Garancher A; Ramaswamy V; Wechsler-Reya RJ
    Annu Rev Neurosci; 2018 Jul; 41():207-232. PubMed ID: 29641939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medulloblastoma: From Myth to Molecular.
    Ramaswamy V; Taylor MD
    J Clin Oncol; 2017 Jul; 35(21):2355-2363. PubMed ID: 28640708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Neurodevelopmental and Molecular Landscape of Medulloblastoma Subgroups: Current Targets and the Potential for Combined Therapies.
    Slika H; Alimonti P; Raj D; Caraway C; Alomari S; Jackson EM; Tyler B
    Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current medulloblastoma subgroup specific clinical trials.
    Thompson EM; Ashley D; Landi D
    Transl Pediatr; 2020 Apr; 9(2):157-162. PubMed ID: 32477916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes.
    Korshunov A; Okonechnikov K; Schrimpf D; Tonn S; Mynarek M; Koster J; Sievers P; Milde T; Sahm F; Jones DTW; von Deimling A; Pfister SM; Kool M
    Acta Neuropathol; 2023 Jun; 145(6):829-842. PubMed ID: 37093271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma Treatment.
    Ray S; Chaturvedi NK; Bhakat KK; Rizzino A; Mahapatra S
    Diagnostics (Basel); 2021 Dec; 12(1):. PubMed ID: 35054230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medulloblastoma: Molecular understanding, treatment evolution, and new developments.
    Liu X; Ding C; Tan W; Zhang A
    Pharmacol Ther; 2020 Jun; 210():107516. PubMed ID: 32105673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Alliance AMBUSH Trial: Rationale and Design.
    Mahajan A; Shih H; Penas-Prado M; Ligon K; Aldape K; Hu LS; Loughan AR; Basso MR; Leeper HE; Nahed BV; Stott SL; Geyer S; Giannini C; Galanis E
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medulloblastoma targeted therapy: From signaling pathways heterogeneity and current treatment dilemma to the recent advances in development of therapeutic strategies.
    Wang Q; Xin X; Dai Q; Sun M; Chen J; Mostafavi E; Shen Y; Li X
    Pharmacol Ther; 2023 Oct; 250():108527. PubMed ID: 37703952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
    Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
    PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Let-7 miRNA Activity as a Prognostic Biomarker of SHH Medulloblastoma.
    Westphal MS; Lee E; Schadt EE; Sholler GS; Zhu J
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation Profiling of Medulloblastoma in a Clinical Setting Permits Sub-classification and Reveals New Outcome Predictions.
    Alharbi M; Mobark N; Bashawri Y; Abu Safieh L; Alowayn A; Aljelaify R; AlSaeed M; Almutairi A; Alqubaishi F; AlSolme E; Ahmad M; Al-Banyan A; Alotabi FE; Serrano J; Snuderl M; Al-Rashed M; Abedalthagafi M
    Front Neurol; 2020; 11():167. PubMed ID: 32265819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted treatment for sonic hedgehog-dependent medulloblastoma.
    Kieran MW
    Neuro Oncol; 2014 Aug; 16(8):1037-47. PubMed ID: 24951114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular markers and potential therapeutic targets in non-WNT/non-SHH (group 3 and group 4) medulloblastomas.
    Menyhárt O; Giangaspero F; Győrffy B
    J Hematol Oncol; 2019 Mar; 12(1):29. PubMed ID: 30876441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic profiling of medulloblastoma reveals novel proteins differentially expressed within each molecular subgroup.
    Narayan V; Jaiswal J; Sugur H; Sd S; Rao S; Chatterjee A; Gowda H; A A; Somanna S; Santosh V
    Clin Neurol Neurosurg; 2020 Sep; 196():106028. PubMed ID: 32580068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI Radiogenomics of Pediatric Medulloblastoma: A Multicenter Study.
    Zhang M; Wong SW; Wright JN; Wagner MW; Toescu S; Han M; Tam LT; Zhou Q; Ahmadian SS; Shpanskaya K; Lummus S; Lai H; Eghbal A; Radmanesh A; Nemelka J; Harward S; Malinzak M; Laughlin S; Perreault S; Braun KRM; Lober RM; Cho YJ; Ertl-Wagner B; Ho CY; Mankad K; Vogel H; Cheshier SH; Jacques TS; Aquilina K; Fisher PG; Taylor M; Poussaint T; Vitanza NA; Grant GA; Pfister S; Thompson E; Jaju A; Ramaswamy V; Yeom KW
    Radiology; 2022 Aug; 304(2):406-416. PubMed ID: 35438562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Classification of Medulloblastoma.
    Kijima N; Kanemura Y
    Neurol Med Chir (Tokyo); 2016 Nov; 56(11):687-697. PubMed ID: 27238212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.